mizoribine has been researched along with Respiratory Syndrome, Acute, Severe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushi, S; Ikejiri, M; Kurane, I; Maruyama, T; Mizutani, T; Morikawa, S; Saijo, M | 1 |
| Bailey, K; Barnard, DL; Carson, DA; Cottam, HB; Day, CW; Heiner, M; Hoopes, J; Lauridsen, L; Lee, J; Li, JK; Montgomery, R; Sidwell, RW; Winslow, S | 1 |
2 other study(ies) available for mizoribine and Respiratory Syndrome, Acute, Severe
| Article | Year |
|---|---|
Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents.
Topics: Animals; Antiviral Agents; Chemistry, Pharmaceutical; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Evaluation Studies as Topic; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Nucleosides; Purines; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Vero Cells | 2007 |
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Topics: Animals; Antiviral Agents; Caco-2 Cells; Cell Survival; Chlorocebus aethiops; Cytokines; Cytopathogenic Effect, Viral; Female; Humans; IMP Dehydrogenase; Lung; Mice; Mice, Inbred BALB C; Mycophenolic Acid; Oligonucleotide Array Sequence Analysis; Ribavirin; Ribonucleosides; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Specific Pathogen-Free Organisms; Vero Cells; Virus Replication | 2006 |